0001209191-23-041772.txt : 20230707 0001209191-23-041772.hdr.sgml : 20230707 20230707125122 ACCESSION NUMBER: 0001209191-23-041772 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20230628 FILED AS OF DATE: 20230707 DATE AS OF CHANGE: 20230707 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ANASTASIO CURT CENTRAL INDEX KEY: 0001032097 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41695 FILM NUMBER: 231076084 MAIL ADDRESS: STREET 1: P.O. BOX 696000 CITY: SAN ANTONIO STATE: TX ZIP: 78269-6000 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Core Laboratories Inc. /DE/ CENTRAL INDEX KEY: 0001958086 STANDARD INDUSTRIAL CLASSIFICATION: OIL, GAS FIELD SERVICES, NBC [1389] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6316 WINDFERN ROAD CITY: HOUSTON STATE: TX ZIP: 77040 BUSINESS PHONE: 713-328-2673 MAIL ADDRESS: STREET 1: 6316 WINDFERN ROAD CITY: HOUSTON STATE: TX ZIP: 77040 FORMER COMPANY: FORMER CONFORMED NAME: Core Laboratories Luxembourg S.A. DATE OF NAME CHANGE: 20221213 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2023-06-28 0 0001958086 Core Laboratories Inc. /DE/ CLB 0001032097 ANASTASIO CURT 6316 WINDFERN ROAD HOUSTON TX 77040 1 0 0 0 Common Shares 0 D Restricted Shares 0.00 Common Shares 6419 D The Restricted Shares were granted to Mr. Anastasio upon his election to the Board of Directors of Core Laboratories Inc., as part of the annual grant given to all non-executive directors on April 1, 2023, and will vest, without performance criteria, on April 1, 2024, at the end of a one-year vesting period from the date of the original non-executive directors' grant, subject to the terms of issuance. /s/ Mark D. Tattoli, Attorney-in-Fact 2023-07-07 EX-24 2 attachment1.htm EX-24 DOCUMENT

										Exhibit 24

POWER OF ATTORNEY

       Know all by these presents, that the undersigned hereby constitutes and
appoints each of Christopher S. Hill, Mark D. Tattoli, and Jonathan A.
Sprague,either of them signing singly, and with full power of substitution, the
undersigned's true and lawful attorney-in-fact to:

       (1)    prepare, execute in the undersigned's name and on the
undersigned's behalf, and submit to the U.S. Securities and Exchange Commission
(the "SEC") a Form ID, including amendments thereto, and any other documents
necessary or appropriate to obtain codes and passwords enabling the undersigned
to make electronic filings with the SEC of reports required by Section 16(a) of
the Securities Exchange Act of 1934 or any rule or regulation of the SEC;

       (2)    execute for and on behalf of the undersigned, in the undersigned's
capacity as an officer and/or director of Core Laboratories N.V. (the
"Company"), Forms 3, 4, and 5 in accordance with Section 16(a) of the Securities
Exchange Act of 1934 and the rules thereunder;

       (3)    do and perform any and all acts for and on behalf of the
undersigned which may be necessary or desirable to complete and execute any such
Form 3, 4, or 5, complete and execute any amendment or amendments thereto, and
timely file such form with the SEC and any stock exchange or similar authority;
and

       (4)    take any other action of any type whatsoever in connection with
the foregoing which, in the opinion of such attorney-in-fact, may be of benefit
to, in the best interest of, or legally required by, the undersigned, it being
understood that the documents executed by such attorney-in-fact on behalf of the
undersigned pursuant to this Power of Attorney shall be in such form and shall
contain such terms and conditions as such attorney-in-fact may approve in such
attorney-in-fact's discretion.

       The undersigned hereby grants to each such attorney-in-fact full power
and authority to do and perform any and every act and thing whatsoever
requisite, necessary, or proper to be done in the exercise of any of the rights
and powers herein granted, as fully to all intents and purposes as the
undersigned might or could do if personally present, with full power of
substitution or revocation, hereby ratifying and confirming all that such
attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall
lawfully do or cause to be done by virtue of this power of attorney and the
rights and powers herein granted. The undersigned acknowledges that the
foregoing attorneys-in-fact, in serving in such capacity at the request of the
undersigned, are not assuming, nor is the Company assuming, any of the
undersigned's responsibilities to comply with Section 16 of the Securities
Exchange Act of 1934.

       This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4, and 5 with respect to the
undersigned's holdings of and transactions in securities issued by the Company,
unless earlier revoked by the undersigned in a signed writing delivered to the
foregoing attorneys-in-fact.

       IN WITNESS WHEREOF, the undersigned have caused this Power of Attorney to
be executed as of this 23rd day of June, 2023.


 /s/ Curtis Anastasio
Curtis Anastasio